Literature DB >> 28960803

Clinical Report: Warsaw Breakage Syndrome with small radii and fibulae.

Sarah Eppley1,2, Robert J Hopkin3, Bryce Mendelsohn1, Anne M Slavotinek1.   

Abstract

We present two new cases of Warsaw Breakage Syndrome (WABS), an autosomal recessive cohesinopathy, in sisters aged 13 and 11 years who both had compound heterozygous mutations in DDX11. After exclusion of Fanconi anemia, Bloom syndrome and Nijmegen breakage syndrome, whole exome sequencing revealed two novel variants-c.1523T>G, predicting (p.Leu508Arg) and c.1949-1G>A (IVS19-1G>A), that were confirmed with Sanger sequencing in both affected individuals. DDX11 encodes an iron-sulfur-containing DNA helicase, and mutations in this gene have been reported in the five WABS cases previously identified to date. The sisters reported here display the distinguishing clinical features of WABS: pre- and post-natal growth restriction, microcephaly, intellectual disability, sensorineural hearing loss with cochlear abnormalities, and facial dysmorphic features. In addition, our cases had early menarche at 8 and 10 years of age, bilateral small thumbs, and the younger, more severely affected sister had small fibulae. These findings broaden the WABS phenotype and the limb malformations demonstrate further clinical overlap with Fanconi anemia and other cohesinopathies, such as Roberts Syndrome.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  DDX11; Warsaw Breakage Syndrome (WABS); chromosome breakage syndrome; cohesinopathy; genomic instability

Mesh:

Substances:

Year:  2017        PMID: 28960803     DOI: 10.1002/ajmg.a.38382

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  Warsaw breakage syndrome: Further clinical and genetic delineation.

Authors:  Ebba Alkhunaizi; Ranad Shaheen; Sanjay Kumar Bharti; Ann M Joseph-George; Karen Chong; Ghada M H Abdel-Salam; Mohammed Alowain; Susan I Blaser; Blake C Papsin; Mohammed Butt; Mais Hashem; Nicole Martin; Ruth Godoy; Robert M Brosh; Fowzan S Alkuraya; David Chitayat
Journal:  Am J Med Genet A       Date:  2018-09-14       Impact factor: 2.802

2.  Warsaw Breakage Syndrome associated DDX11 helicase resolves G-quadruplex structures to support sister chromatid cohesion.

Authors:  Janne J M van Schie; Atiq Faramarz; Jesper A Balk; Grant S Stewart; Erika Cantelli; Anneke B Oostra; Martin A Rooimans; Joanna L Parish; Cynthia de Almeida Estéves; Katja Dumic; Ingeborg Barisic; Karin E M Diderich; Marjon A van Slegtenhorst; Mohammad Mahtab; Francesca M Pisani; Hein Te Riele; Najim Ameziane; Rob M F Wolthuis; Job de Lange
Journal:  Nat Commun       Date:  2020-08-27       Impact factor: 14.919

3.  Warsaw breakage syndrome DDX11 helicase acts jointly with RAD17 in the repair of bulky lesions and replication through abasic sites.

Authors:  Takuya Abe; Masato Ooka; Ryotaro Kawasumi; Keiji Miyata; Minoru Takata; Kouji Hirota; Dana Branzei
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-30       Impact factor: 11.205

Review 4.  Molecular and Cellular Functions of the Warsaw Breakage Syndrome DNA Helicase DDX11.

Authors:  Francesca M Pisani; Ettore Napolitano; Luisa M R Napolitano; Silvia Onesti
Journal:  Genes (Basel)       Date:  2018-11-21       Impact factor: 4.096

5.  Two further patients with Warsaw breakage syndrome. Is a mild phenotype possible?

Authors:  Roberta Bottega; Luisa M R Napolitano; Anna Carbone; Enrico Cappelli; Fabio Corsolini; Silvia Onesti; Anna Savoia; Paolo Gasparini; Flavio Faletra
Journal:  Mol Genet Genomic Med       Date:  2019-03-28       Impact factor: 2.183

Review 6.  Role of the DDX11 DNA Helicase in Warsaw Breakage Syndrome Etiology.

Authors:  Diana Santos; Mohammad Mahtab; Ana Boavida; Francesca M Pisani
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

7.  Rad51-mediated replication of damaged templates relies on monoSUMOylated DDK kinase.

Authors:  Chinnu Rose Joseph; Sabrina Dusi; Michele Giannattasio; Dana Branzei
Journal:  Nat Commun       Date:  2022-05-05       Impact factor: 17.694

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.